Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022

SELL
$69.73 - $142.9 $105,292 - $215,779
-1,510 Closed
0 $0
Q4 2021

Jan 19, 2022

BUY
$134.56 - $217.97 $1,345 - $2,179
10 Added 0.67%
1,510 $216,000
Q1 2021

May 04, 2021

BUY
$112.98 - $319.93 $169,470 - $479,895
1,500 New
1,500 $272,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $964M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Oxinas Partners Wealth Management LLC Portfolio

Follow Oxinas Partners Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxinas Partners Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxinas Partners Wealth Management LLC with notifications on news.